2023 Annual Meeting | S37 - Movement Disorders: Phenotyping and Biomarkers
Program Materials Program Evaluations
| Guillaume Lamotte, MD | Dr. Lamotte has nothing to disclose. |
| Beate Ritz | Beate Ritz has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Foundation for Psychocultural Research. Beate Ritz has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Tillery Korein Law firm. Beate Ritz has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Andrus Wagstaff law firm. The institution of Beate Ritz has received research support from NIH. The institution of Beate Ritz has received research support from MJFox foundation. The institution of Beate Ritz has received research support from Dept of Defense. The institution of Beate Ritz has received research support from NASA. The institution of Beate Ritz has received research support from MSA foundation. |
| Marianna Cortese, MD, PhD | Dr. Cortese has received personal compensation in the range of $500-$4,999 for serving as a speaker at educational event with Roche. |
| Ben Corcoran | Ben Corcoran has nothing to disclose. |
| Colin Waltz, Other | Mr. Waltz has nothing to disclose. |
| Nikolaus McFarland, MD, PhD, FAAN | Dr. McFarland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sutter Health. The institution of Dr. McFarland has received research support from NIH. Dr. McFarland has received publishing royalties from a publication relating to health care. |
| Brent L. Fogel, MD, PhD, FAAN | Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for National Ataxia Foundation. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Ataxia Global Initiative. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Today. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Genetics. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Genes. The institution of Dr. Fogel has received research support from the National Institutes of Health. The institution of Dr. Fogel has received research support from the National Ataxia Foundation. The institution of an immediate family member of Dr. Fogel has received research support from the National Institutes of Health, the National Science Foundation, and the Department of Defense. |
| Samuel A. Frank, MD, FAAN | Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage Therapeutics. Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for uniQure. The institution of Dr. Frank has received research support from Huntington's Disease Society of America. The institution of Dr. Frank has received research support from Roche/Genentech. The institution of Dr. Frank has received research support from CHDI Foundation. The institution of Dr. Frank has received research support from Huntington Study Group. The institution of Dr. Frank has received research support from Triplet Therapeutics. |
| Gal Bitan, PhD | The institution of Dr. Bitan has received research support from NIH/NIA. The institution of Dr. Bitan has received research support from NIH/NINDS. The institution of Dr. Bitan has received research support from The Alzheimer's Association, The Michael J. Fox Foundation, Weston Brain Institute, and Alzheimer's Research UK Biomarkers Across Neurodegenerative Diseases (BAND 3). The institution of Dr. Bitan has received research support from CurePSP. The institution of Dr. Bitan has received research support from The Michael J. Fox Foundation. The institution of Dr. Bitan has received research support from The National Ataxia Foundation. The institution of Dr. Bitan has received research support from Cure Sanfilippo Foundation. Dr. Bitan has received personal compensation in the range of $10,000-$49,999 for serving as a Tutor with Pioneer Academics. |
| Maria Alejandra Gonzalez Duarte, MD, FAAN | Dr. Gonzalez Duarte has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Anylam . The institution of Dr. Gonzalez Duarte has received research support from Pfizer. |
| Ningshan Wang, MD, PhD | Dr. Wang has nothing to disclose. |
| Maryam Tanveer | Ms. Tanveer has nothing to disclose. |
| Suman Dutta, PhD | Dr. Dutta has nothing to disclose. |
| Leony Fenwick, Other | Miss Fenwick has nothing to disclose. |
| Karen Hildebrand, Other | Miss Hildebrand has nothing to disclose. |
| Jeff M. Bronstein, MD, PhD | Dr. Bronstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ultragenyx. The institution of Dr. Bronstein has received research support from NIH. The institution of Dr. Bronstein has received research support from Levine Foundation. |
| Jose-Alberto Palma, MD, PhD, FAAN | Dr. Palma has received personal compensation for serving as an employee of Novartis. Dr. Palma has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Clinical Autonomic Research. The institution of Dr. Palma has received research support from National Institutes of Health. Dr. Palma has received publishing royalties from a publication relating to health care. |
| Oleg Yerokhin Yerstein, MD | Dr. Yerstein has nothing to disclose. |
| SIlvia Rota, MD | Dr. Rota has nothing to disclose. |
| Rajeev Kumar, MD, FRCPC | The institution of Dr. Kumar has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Supernus. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. The institution of Dr. Kumar has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Teva Pharmaceuticals. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Annexon. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acorda Therapeutics. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cerevel Therapeutics. Dr. Kumar has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Impel Pharma. Dr. Kumar has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Supernus. The institution of Dr. Kumar has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda Therapeutics. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Kumar has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Research Catalyst, LLC. Dr. Kumar has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for CenExel RMCR. Dr. Kumar has stock in Research Catalyst, LLC. Dr. Kumar has stock in CenExel. The institution of Dr. Kumar has received research support from Supernus. The institution of Dr. Kumar has received research support from Sage Therapeutics. The institution of Dr. Kumar has received research support from Prilenia Therapeutics. The institution of Dr. Kumar has received research support from Roche. The institution of Dr. Kumar has received research support from Triplet Therapeutics. The institution of Dr. Kumar has received research support from CHDI Foundation. The institution of Dr. Kumar has received research support from Neurocrine Biosciences. The institution of Dr. Kumar has received research support from Biovie. The institution of Dr. Kumar has received research support from Neuroderm. The institution of Dr. Kumar has received research support from Sanofi. The institution of Dr. Kumar has received research support from Addex Pharma. The institution of Dr. Kumar has received research support from Integrative Research Laboratories. The institution of Dr. Kumar has received research support from Takeda Pharmaceuticals. The institution of Dr. Kumar has received research support from Neuraly. The institution of Dr. Kumar has received research support from Abbvie. The institution of Dr. Kumar has received research support from Cerevel Therapeutics. The institution of Dr. Kumar has received research support from Transposon Therapeutics. The institution of Dr. Kumar has received research support from Lundbeck. The institution of Dr. Kumar has received research support from Biohaven. The institution of Dr. Kumar has received research support from Revance Therapeutics. The institution of Dr. Kumar has received research support from Impax Laboratories. The institution of Dr. Kumar has received research support from Pharma Two B. The institution of Dr. Kumar has received research support from Enterin. The institution of Dr. Kumar has received research support from CND Life Sciences. The institution of Dr. Kumar has received research support from Neuron23. The institution of Dr. Kumar has received research support from Annexon Biosciences. The institution of Dr. Kumar has received research support from Annovis. The institution of Dr. Kumar has received research support from PTC Therapeutics. The institution of Dr. Kumar has received research support from Uniqure. The institution of Dr. Kumar has received research support from Alexza. The institution of Dr. Kumar has received research support from SparkNeuro. The institution of Dr. Kumar has received research support from Praxis. The institution of Dr. Kumar has received research support from Scion Neurostim. The institution of Dr. Kumar has received research support from Cognition Therapeutics. The institution of Dr. Kumar has received research support from Eli Lilly. Dr. Kumar has received personal compensation in the range of $100,000-$499,999 for serving as a Medical Director with CenExel RMCR. Dr. Kumar has received personal compensation in the range of $1,000,000+ for serving as a Managing Member with Research Catalyst, LLC. |
| Kathryn Howe | Ms. Howe has nothing to disclose. |
| Magdaline Mwangi | Miss Mwangi has nothing to disclose. |
| Daniela Markovic, Other | Ms. Markovic has nothing to disclose. |
| Mitchell G. Miglis, MD, FAAN | Dr. Miglis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Infinite MD. Dr. Miglis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint, LLC. Dr. Miglis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for 2nd MD. Dr. Miglis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MED-IQ. Dr. Miglis has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Van Cott and Talamante. Dr. Miglis has received publishing royalties from a publication relating to health care. |
| Christopher Adams, MD | Dr. Adams has stock in Medtronic. |
| Horacio C. Kaufmann, MD, FAAN | Dr. Kaufmann has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Theravance. Dr. Kaufmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly USA. Dr. Kaufmann has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda Pharmaceuticals. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ono Pharma UK Ltd. Dr. Kaufmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vaxxinity. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Spinger. The institution of Dr. Kaufmann has received research support from Biogen. Dr. Kaufmann has received publishing royalties from a publication relating to health care. |
| Simon Hornung | Mr. Hornung has nothing to disclose. |
| Darice Wong | Darice Wong has nothing to disclose. |
| Audrey Omidsalar | Miss Omidsalar has nothing to disclose. |
| Kjetil Bjornevik, MD, PhD | The institution of Dr. Bjornevik has received research support from Michael J. Fox Foundation. The institution of Dr. Bjornevik has received research support from National Multiple Sclerosis Society. The institution of Dr. Bjornevik has received research support from Department of Defense. |
| Michael Soileau, MD, FAAN | The institution of Dr. Soileau has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. The institution of Dr. Soileau has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. The institution of Dr. Soileau has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. The institution of Dr. Soileau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. The institution of Dr. Soileau has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine PHarmaceuticals. The institution of Dr. Soileau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal Pharmaceuticals. Dr. Soileau has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Abbvie. Dr. Soileau has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal. Dr. Soileau has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kiran. The institution of Dr. Soileau has received research support from Abbvie. The institution of Dr. Soileau has received research support from Cerevel. The institution of Dr. Soileau has received research support from Praxis. The institution of Dr. Soileau has received research support from CND Life Sciences. The institution of Dr. Soileau has received research support from Teva. The institution of Dr. Soileau has received research support from Abbott. The institution of Dr. Soileau has received research support from Jazz Pharmaceuticals. The institution of Dr. Soileau has received research support from Scion. Dr. Soileau has received publishing royalties from a publication relating to health care. |
| Roy L. Freeman, MD | Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regenacy. Dr. Freeman has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurobo. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli-Lilly. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theravance. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Inhibikase. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Freeman has stock in Neurobo. Dr. Freeman has stock in Cutaneous NeuroDiagnostics. The institution of Dr. Freeman has received research support from NIH. The institution of Dr. Freeman has received research support from Theravance. The institution of Dr. Freeman has received research support from Biohaven. The institution of Dr. Freeman has received research support from Lundbeck. |
| Daniel Gerke | Mr. Gerke has nothing to disclose. |
| Un Jung Kang, MD, FAAN | Dr. Kang has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Amprion. Dr. Kang has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Kang has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Experimental Neurology. The institution of Dr. Kang has received research support from NIH. The institution of Dr. Kang has received research support from Parkinson's Foundation. The institution of Dr. Kang has received research support from Michael J Fox Foundation for Parkinson's Research. |
| Mya C. Schiess, MD | Dr. Schiess has nothing to disclose. |
| Albert Hung, MD, PhD | The institution of Dr. Hung has received research support from Parkinson's Foundation. The institution of Dr. Hung has received research support from Rho, Inc.. |
| Hubert H. Fernandez, MD, FAAN | Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevel. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Fernandez has received research support from Biogen. The institution of Dr. Fernandez has received research support from Michael J Fox Founda. The institution of Dr. Fernandez has received research support from Roche. The institution of Dr. Fernandez has received research support from Parkinson Foundation. The institution of Dr. Fernandez has received research support from UCB. Dr. Fernandez has received publishing royalties from a publication relating to health care. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as a Steering Committee/Advisory Committee Member with Parkinson Study Group. |
| Nicola Mulholland | Nicola Mulholland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AAA. Nicola Mulholland has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sirtex. |
| Roy Alcalay, MD | Dr. Alcalay has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyme/Sanofi. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Therapeutics. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Caraway. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avrobio. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. The institution of Dr. Alcalay has received research support from NIH. The institution of Dr. Alcalay has received research support from DoD. The institution of Dr. Alcalay has received research support from Michael J. Fox Foundation. Dr. Alcalay has received research support from Parkinson's Foundation. |
| Michael Schwarzschild, MD, PhD | The institution of Dr. Schwarzschild has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial Biotech (indirectly, as a service of the Parkinson Study Group service). The institution of Dr. Schwarzschild has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen (indirectly, as a service of the Parkinson Study Group service). The institution of Dr. Schwarzschild has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB (indirectly, as a service of the Parkinson Study Group service). Dr. Schwarzschild has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. The institution of Dr. Schwarzschild has received research support from NIH. The institution of Dr. Schwarzschild has received research support from Parkinson's Foundation. The institution of Dr. Schwarzschild has received research support from Michael J Fox Foundation. The institution of Dr. Schwarzschild has received research support from Farmer Family Foundation. Dr. Schwarzschild has a non-compensated relationship as a Chair, Executive Committee with the Parkinson Study Group that is relevant to AAN interests or activities. |
| Todd D. Levine, MD | Dr. Levine has received personal compensation for serving as an employee of CND life sciences . Dr. Levine has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Nufactor. Dr. Levine has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Grifols. Dr. Levine has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for PNA. Dr. Levine has stock in CND Life Sciences. Dr. Levine has stock in Corinthian reference lab. |
| Emily Tharp, MD | Dr. Tharp has nothing to disclose. |
| Mark Gudesblatt, MD | No disclosure on file |
| Mohammad Shahnawaz, PhD | The institution of Dr. Shahnawaz has received research support from American Parkinson Disease Association. The institution of Dr. Shahnawaz has received research support from NIH. The institution of Dr. Shahnawaz has received research support from Texas Alzheimer's Research & Care Consortium . Dr. Shahnawaz has received intellectual property interests from a discovery or technology relating to health care. |
| Danielle Feigenbaum, MD | Dr. Feigenbaum has nothing to disclose. |
| Hash Brown Taha | Mr. Taha has nothing to disclose. |
| Alberto Ascherio, MD, PhD | The institution of Dr. Ascherio has received research support from NIH and US Department of Defense . |
| Jay L Alberts, PhD | The institution of Dr. Alberts has received research support from NIH. Dr. Alberts has received intellectual property interests from a discovery or technology relating to health care. Dr. Alberts has received personal compensation in the range of $500-$4,999 for serving as a Member, Health and Wellness Council with Peloton Interactive. |
| Luis Alberto Sierra, Jr. | Mr. Sierra has nothing to disclose. |
| Clementina Julia Ullman | Miss Ullman has nothing to disclose. |
| Miriam M. Sklerov, MD | The institution of Dr. Sklerov has received research support from National Institutes of Health (NIH). The institution of Dr. Sklerov has received research support from University of North Carolina Department of Medicine. |
| Juliet Staunton | Ms. Staunton has nothing to disclose. |
| Henry J. O'Connell, Other | Mr. O'Connell has received personal compensation for serving as an employee of Canary Speech, Inc. |
| Alexandra Rizos, Other | An immediate family member of Mrs. Rizos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. An immediate family member of Mrs. Rizos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. An immediate family member of Mrs. Rizos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GKC. An immediate family member of Mrs. Rizos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial. An immediate family member of Mrs. Rizos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cynapsus. An immediate family member of Mrs. Rizos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. An immediate family member of Mrs. Rizos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lobsor. An immediate family member of Mrs. Rizos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stada. An immediate family member of Mrs. Rizos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zambon. An immediate family member of Mrs. Rizos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Profile Pharma. An immediate family member of Mrs. Rizos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Synovion. An immediate family member of Mrs. Rizos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. An immediate family member of Mrs. Rizos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theravance. An immediate family member of Mrs. Rizos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scion. An immediate family member of Mrs. Rizos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Britannia. Mrs. Rizos has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Britannia. An immediate family member of Mrs. Rizos has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Britannia. An immediate family member of Mrs. Rizos has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. An immediate family member of Mrs. Rizos has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zambon. An immediate family member of Mrs. Rizos has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. An immediate family member of Mrs. Rizos has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boehringer Ingelheim. An immediate family member of Mrs. Rizos has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Nature Parkinson's Journal. The institution of an immediate family member of Mrs. Rizos has received research support from EU. The institution of an immediate family member of Mrs. Rizos has received research support from Parkinson's UK. The institution of an immediate family member of Mrs. Rizos has received research support from Parkinson's Foundation. The institution of an immediate family member of Mrs. Rizos has received research support from Wellcome trust. The institution of an immediate family member of Mrs. Rizos has received research support from MRC. An immediate family member of Mrs. Rizos has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Mrs. Rizos has received publishing royalties from a publication relating to health care. An immediate family member of Mrs. Rizos has received publishing royalties from a publication relating to health care. |
| Magdalena Krbot Skoric | Magdalena Krbot Skoric has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. |
| Hemant Kumar Pandey, MD | Dr. Pandey has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for BIOHAVEN. |
| Morgan McGrath | Mrs. McGrath has received research support from NIH. Mrs. McGrath has received intellectual property interests from a discovery or technology relating to health care. |
| Melita Talene Petrossian, MD | An immediate family member of Dr. Petrossian has received personal compensation for serving as an employee of Nile AI. An immediate family member of Dr. Petrossian has received personal compensation for serving as an employee of Neurolutions. Dr. Petrossian has received personal compensation for serving as an employee of Kandu Health. Dr. Petrossian has stock in Kandu Health. An immediate family member of Dr. Petrossian has stock in Nile AI. An immediate family member of Dr. Petrossian has stock in Neurolutions. An immediate family member of Dr. Petrossian has stock in Nova Signal. An immediate family member of Dr. Petrossian has stock in Imperative Care. The institution of Dr. Petrossian has received research support from Praxis. The institution of Dr. Petrossian has received research support from NIH. |
| Stuart H. Isaacson, MD, FAAN | The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sunovion. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for acorda. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for adamas. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neuroderm. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for amneal. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for adamas. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acadia. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. |
| Charles H. Adler, MD, PhD, FAAN | Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Adler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CND Life Sci. Dr. Adler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precon. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. The institution of Dr. Adler has received research support from NIH. The institution of Dr. Adler has received research support from Michael J. Fox Foundation. The institution of Dr. Adler has received research support from Arizona Biomedical Research Commission. Dr. Adler has received publishing royalties from a publication relating to health care. |
| Bailey *use 388592 Bellaire | Bailey Bellaire has received personal compensation for serving as an employee of CND Life Sciences. |
| Brooke Erika Hjelm, PhD | Dr. Hjelm has nothing to disclose. |
| Emily Tamadonfar, MD | Dr. Tamadonfar has nothing to disclose. |
| K *Use 019583 Ray Chaudhuri, MD,Other | Prof. Ray Chaudhuri has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Advisory board recent: AbbVie, UCB, GKC, Bial, Cynapsus, Lobsor, Stada, Zambon, Profile Pharma, Synovion, Roche, Therevance, Scion, Britannia, Acadia, 4D Pharma. Prof. Ray Chaudhuri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie, Britannia, UCB, Zambon, Novartis, Boeringer Ingelheim, Bial, Kyowa Kirin, SK Pharma . Prof. Ray Chaudhuri has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for GMC. The institution of Prof. Ray Chaudhuri has received research support from EU Horizon 2020, Parkinson's UK, NIHR, Parkinson's Foundation, Wellcome Trust Aacdemic grants over 2 years ago: Kirby Laing Foundation, MRC. Prof. Ray Chaudhuri has received publishing royalties from a publication relating to health care. |
| Mark F. Lew, MD, FAAN | Dr. Lew has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus. Dr. Lew has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for kyowa. Dr. Lew has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for neurocrine. Dr. Lew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acorda. Dr. Lew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Lew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RegenXBio. Dr. Lew has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Lew has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Kyowa. Dr. Lew has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for acorda. The institution of Dr. Lew has received research support from MJFF. Dr. Lew has received research support from NIH. |
| Katherine C. Hughes, PhD | Dr. Hughes has received personal compensation for serving as an employee of Optum. |
| Mandy Koop | No disclosure on file |
| Kelly Lauren Block, DO | Dr. Block has nothing to disclose. |
| Nour Elabed, Other | Miss Elabed has nothing to disclose. |
| Pravin Khemani, MD, FAAN | Dr. Khemani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Khemani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cala Trio. Dr. Khemani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. |
| Christopher H. Gibbons, MD, FAAN | Dr. Gibbons has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Autonomic Neuroscience. Dr. Gibbons has stock in CND Life Sciences. Dr. Gibbons has received personal compensation in the range of $5,000-$9,999 for serving as a Expert Advisor with Department of Justice. |
| Andrew Liu, MD | Dr. Liu has received personal compensation in the range of $0-$499 for serving as a Consultant for Darwin Research Group. |
| Alexandru C. Barboi, MD | Dr. Barboi has nothing to disclose. |
| Anson Rosenfeldt | Anson Rosenfeldt has received personal compensation for serving as an employee of Cleveland Clinic. Anson Rosenfeldt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Enspire DBS. The institution of Anson Rosenfeldt has received research support from Michael J. Fox Foundation. The institution of Anson Rosenfeldt has received research support from National Institute of Health. The institution of Anson Rosenfeldt has received research support from Department of Defense. Anson Rosenfeldt has received intellectual property interests from a discovery or technology relating to health care. |
| Jessika Suescun, MD | Dr. Suescun has nothing to disclose. |
| Aline Duarte Folle, PhD | Dr. Duarte Folle has received research support from Michael J Fox Foundation. Dr. Duarte Folle has received research support from Multiple System Atrophy (MSA) Coalition. |
| Mario H. Torres | Mr. Torres has nothing to disclose. |
| Irish Pearl Del Rosario, Other | Ms. DEL ROSARIO has nothing to disclose. |
| Timothy Michael Ellmore, PhD | The institution of Prof. Ellmore has received research support from NIMH. |
| Sarah Hamm-Alvarez | Sarah Hamm-Alvarez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oyster Point. The institution of Sarah Hamm-Alvarez has received research support from Oyster Point. |
| Katarina Rukavina | The institution of Ms. Rukavina has received research support from NIHR BRC. The institution of Ms. Rukavina has received research support from Parkinson's UK. Ms. Rukavina has received personal compensation in the range of $0-$499 for serving as a Speaker or Writer with Valid Insight, Profile Pharma and Britannia. . |
| Marie-Helene Saint-Hilaire, MD, FRCPC, FAAN | Dr. Saint-Hilaire has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acorda. Dr. Saint-Hilaire has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Altec. Dr. Saint-Hilaire has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Watermark. Dr. Saint-Hilaire has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Parkinson study group. |
| Virgilio Gerald H. Evidente, MD, FAAN | Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal. Dr. Evidente has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Evidente has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Ipsen. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. The institution of Dr. Evidente has received research support from Neuraly. The institution of Dr. Evidente has received research support from Revance. The institution of Dr. Evidente has received research support from CND. The institution of Dr. Evidente has received research support from Lundbeck. The institution of Dr. Evidente has received research support from Abbvie. The institution of Dr. Evidente has received research support from Acadia. The institution of Dr. Evidente has received research support from Aptinyx. The institution of Dr. Evidente has received research support from Aeon. The institution of Dr. Evidente has received research support from Bukwang Pharmaceuticals. The institution of Dr. Evidente has received research support from Jazz Pharmaceuticals. The institution of Dr. Evidente has received research support from Scion Neurostim. The institution of Dr. Evidente has received research support from Theravance Biopharma. |
| Shruti Singh Kakan, PhD | Miss Singh Kakan has nothing to disclose. |
| Simon Laganiere, MD | Dr. Laganiere has received research support from HDSA. |
| Jill L. Ostrem, MD, FAAN | Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. Dr. Ostrem has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz . Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Superness. Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AcureX. Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders. The institution of Dr. Ostrem has received research support from Neuroderm. The institution of Dr. Ostrem has received research support from Boston Scientific. The institution of Dr. Ostrem has received research support from Medtronic. The institution of Dr. Ostrem has received research support from Rune. |
| Ihtsham Haq, MD, FAAN | The institution of Dr. Haq has received research support from NINDS. The institution of Dr. Haq has received research support from the Parkinson's Foundation. The institution of Dr. Haq has received research support from NIMH. Dr. Haq has a non-compensated relationship as a consultant with Medtronics that is relevant to AAN interests or activities. Dr. Haq has a non-compensated relationship as a consultant with Boston Scientific that is relevant to AAN interests or activities. Dr. Haq has a non-compensated relationship as a consultant with Abbott that is relevant to AAN interests or activities. |
| Claire Henchcliffe, MD, PhD, FAAN | Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AskBio. Dr. Henchcliffe has received personal compensation in the range of $0-$499 for serving as a Consultant for Certara. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Meira GTx. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ProJenX. Dr. Henchcliffe has stock in Axent Biosciences Inc. The institution of Dr. Henchcliffe has received research support from Weston Brain Institute. The institution of Dr. Henchcliffe has received research support from Blue Rock Therapeutics. |